Cell and Gene Therapy in Canada - Insights Magazine Back Bay in the NewsBack Bay Life Science AdvisorsJune 2, 2022Cell Therapy, Drug Development, Biopharma, Funding, Partnering, Canada
From Drug Target Inhibition to Degradation: a TACtical Strategy - Nature Biopharma Dealmakers Back Bay in the NewsBack Bay Life Science AdvisorsJune 2, 2022IPOs, VC, Drug Development, Investment Banking
Investment Banking Spotlight: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals Back Bay Deal TeamInvestment Banking TeamFebruary 23, 2021Biotech, M&A, Drug Development, Cannabidiol, Blockbuster, Life Sciences
Analysis Of The Non-Alcoholic Steatohepatitis Drug Pipeline & Market Blog, White PaperBack Bay Life Science AdvisorsDecember 15, 2020NASH, Drug Development, Clinical Stage
Saving Antibiotic Drug Development Back Bay in the NewsBack Bay Life Science AdvisorsJune 29, 2020Anti-Infectives, Anti-Microbials, Drug Development
Artificial Intelligence and Drug Discovery Insights, BlogBack Bay Life Science AdvisorsJanuary 1, 2020AI, Drug Development
STAT NEWS: Microbiome Drug Development a Rapidly Evolving Field Insights, Back Bay in the News, Life Science MediaBack Bay Life Science AdvisorsNovember 13, 2019Microbiome, Drug Development
